Related Experiment Video
Updated: Jul 9, 2026

11:42
Iterative Optimization of DNA Duplexes for Crystallization of SeqA-DNA Complexes
Published on: November 1, 2012
Type II dehydroquinase: molecular replacement with many copies.
Kirsty Anne Stewart1, David Alexander Robinson, Adrian Jonathan Lapthorn
1Department of Chemistry, University of Glasgow, Glasgow G12 8QQ, Scotland.
Acta Crystallographica. Section D, Biological Crystallography
|December 21, 2007
Summary
Type II dehydroquinase protein forms dodecamers with cubic symmetry. Different crystal forms present challenges for molecular replacement, with one unusual triclinic form analyzed.
Area of Science:
- Structural biology
- Crystallography
- Protein science
Background:
- Type II dehydroquinase is a 150-amino-acid protein that forms dodecamers with cubic symmetry in solution.
- Crystallization can lead to various crystal forms, including those with coincident biological and crystallographic symmetry, or those with significant noncrystallographic symmetry in low-symmetry systems.
- These diverse crystal forms complicate structure determination using molecular replacement.
Purpose of the Study:
- To describe structure solutions for Type II dehydroquinase using molecular replacement, focusing on challenging crystal forms.
- To assess the performance of commonly used molecular replacement software packages.
- To analyze an unusual triclinic crystal form and elucidate its true crystallographic nature.
Main Methods:
- Molecular replacement techniques were employed for structure solution.
- Four different molecular replacement software packages were evaluated.
- Crystallographic analysis, including refinement and symmetry analysis, was performed on a specific triclinic crystal form.
Main Results:
- Structure solutions were obtained for three distinct crystal forms of Type II dehydroquinase.
- Performance of molecular replacement packages varied significantly depending on crystal symmetry and complexity.
- An unusual triclinic crystal form containing 16 dodecamers was analyzed and reclassified as an F-centered cubic crystal with frustrated symmetry, not a superlattice structure.
Conclusions:
- Molecular replacement strategies must be adapted to the specific crystallographic challenges posed by different protein crystal forms.
- The choice of molecular replacement software can critically impact the success of structure solution.
- The detailed analysis of the triclinic crystal form provides new insights into protein crystallization and symmetry in crystallography.

